A new trading day began on Tuesday, with Puma Biotechnology Inc (NASDAQ: PBYI) stock price up 0.91% from the previous day of trading, before settling in for the closing price of $3.29. PBYI’s price has ranged from $2.22 to $4.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -3.28%. Meanwhile, its annual earnings per share averaged -32.80%. With a float of $37.38 million, this company’s outstanding shares have now reached $49.62 million.
Let’s determine the extent of company efficiency that accounts for 172 employees. In terms of profitability, gross margin is 72.4%, operating margin of 16.01%, and the pretax margin is 13.73%.
Puma Biotechnology Inc (PBYI) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Puma Biotechnology Inc is 24.69%, while institutional ownership is 53.40%. The most recent insider transaction that took place on May 21 ’25, was worth 191,310. Before that another transaction happened on Jan 02 ’25, when Company’s Chief Financial Officer sold 10,227 for $3.15, making the entire transaction worth $32,232. This insider now owns 152,295 shares in total.
Puma Biotechnology Inc (PBYI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -32.80% per share during the next fiscal year.
Puma Biotechnology Inc (NASDAQ: PBYI) Trading Performance Indicators
Here are Puma Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.71. Likewise, its price to free cash flow for the trailing twelve months is 5.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.77, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.32 in one year’s time.
Technical Analysis of Puma Biotechnology Inc (PBYI)
Looking closely at Puma Biotechnology Inc (NASDAQ: PBYI), its last 5-days average volume was 0.53 million, which is a jump from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 29.68%. Additionally, its Average True Range was 0.19.
During the past 100 days, Puma Biotechnology Inc’s (PBYI) raw stochastic average was set at 62.98%, which indicates a significant increase from 55.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.61% in the past 14 days, which was higher than the 61.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.10, while its 200-day Moving Average is $2.95. However, in the short run, Puma Biotechnology Inc’s stock first resistance to watch stands at $3.42. Second resistance stands at $3.53. The third major resistance level sits at $3.66. If the price goes on to break the first support level at $3.18, it is likely to go to the next support level at $3.05. Should the price break the second support level, the third support level stands at $2.94.
Puma Biotechnology Inc (NASDAQ: PBYI) Key Stats
With a market capitalization of 164.55 million, the company has a total of 49,631K Shares Outstanding. Currently, annual sales are 230,470 K while annual income is 30,280 K. The company’s previous quarter sales were 46,010 K while its latest quarter income was 2,970 K.
